샘플 요청 목록

 카트 문의
시장보고서
상품코드
1793891

세계의 혈전 치료 시장

Thrombus Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 296 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 혈전 치료 시장은 2030년까지 557억 달러에 달할 전망

2024년에 408억 달러로 추정되는 세계의 혈전 치료 시장은 2024-2030년의 분석 기간에 CAGR 5.3%로 성장하며, 2030년에는 557억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 심방 혈전형은 CAGR 6.8%를 기록하며, 분석 기간 종료시에는 280억 달러에 달할 것으로 예측됩니다. 우심방 혈전형 부문의 성장률은 분석 기간 중 CAGR 3.6%로 추정됩니다.

미국 시장은 111억 달러로 추정, 중국은 CAGR 8.7%로 성장 예측

미국의 혈전 치료 시장은 2024년에 111억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 113억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 8.7%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.5%와 5.3%로 예측됩니다. 유럽에서는 독일이 CAGR 3.5%로 성장할 것으로 예측됩니다.

세계의 혈전 치료 시장 - 주요 동향과 촉진요인 정리

혈전 관리는 응급 대응에서 표적 개입으로 진화?

과거에는 항응고요법이나 기계적 혈전제거술과 같은 응급 개입을 중심으로 반응적으로 이루어졌던 혈전 치료는 현재 큰 변화의 시기를 맞이하고 있습니다. 임상적 이해가 깊어지고 치료 알고리즘이 발전함에 따라 혈전 관리는 더 일찍, 더 정확하게, 더 환자 맞춤형 전략으로 전환되고 있습니다. 혈전(혈관 내에 형성된 혈액 덩어리)은 심부정맥혈전증(DVT), 폐색전증(PE), 심근경색, 허혈성 뇌졸중과 같은 생명을 위협하는 질환을 유발할 수 있습니다. 전 세계에서 혈전색전증에 대한 부담은 인구의 고령화와 좌식 생활습관으로 인해 증가하고 있으며, 의료 시스템은 확장 가능하고 진보된 치료 접근법을 지속적으로 요구하고 있습니다.

현대 혈전 치료는 약물요법, 카테터를 이용한 중재술, 예방의학이라는 세 가지를 특징으로 합니다. 항응고제가 대부분의 치료 계획의 기초가 되는 것은 변함없지만, 카테터를 이용한 혈전 용해 요법, 흡입 혈전 제거술, 새로운 기계 장치 등이 고위험군이나 난치성 환자에서 보편화되고 있습니다. 또한 혈전 인지 및 검출 능력의 향상으로 혈전 조기 진단이 가능해져, 때로는 임상 증상이 나타나기 전에도 고위험군 환자군에 대한 선제적 치료가 가능해졌습니다. 이러한 패러다임의 변화는 혈전 치료를 위기 관리에서 지속적인 위험 감소와 개인 맞춤형 치료로 재정의하고 있습니다.

약물 혁신과 혈관내 장치는 어떻게 치료의 기준을 재정의하고 있는가?

약리학적인 측면에서 아픽사반, 리바록사반, 에독사반과 같은 직접 경구용 항응고제(DOACs)의 개발은 와파린에 비해 예측 가능한 약동학, 모니터링의 필요성 감소, 출혈 위험의 감소를 가져와 혈전 치료의 판도를 바꾸어 놓았습니다. 이 약제들은 심방세동에서 심방세동, 심방세동, PE, 뇌졸중 예방을 위해 병원과 외래에서 점점 더 많이 사용되고 있습니다. 또한 수술 및 외상 환자의 안전성을 높이기 위해 선택성이 높은 차세대 항혈전제 및 역전제 연구도 진행 중입니다.

한편, 기계적 혈전 제거술과 카테터 직접 혈전 용해 요법(CDT)의 등장은 급성 혈전 사건에 대한 치료 프로토콜을 크게 변화시키고 있습니다. 이러한 저침습적 시술을 통해 표적 혈전 제거 및 국소 약물전달이 가능해져 전신 노출 및 출혈 합병증을 최소화할 수 있습니다. 흡입 카테터, 자가 확장형 스텐트 리트리버, 초음파 보조 혈전 용해 시스템 등의 장치는 뇌, 폐, 관상동맥, 말초 등의 혈관층에서 효과를 높이기 위해 미세하게 조정되고 있습니다. 기계적 치료와 약리학적 치료를 결합한 하이브리드 치료가 가능해짐에 따라 특히 즉각적인 관류 회복이 필요한 뇌졸중 및 뇌혈관성 심장질환 환자에서 혈전 용해가 빨라지고 기능적 예후가 개선되고 있습니다.

조기발견, 리스크 프로파일링, 예방요법이 시장을 확대할 수 있는가?

혈전 치료의 중요한 동향은 예방과 조기 위험 파악에 초점을 맞추고 있다는 점입니다. 웨어러블 기술, AI 지원 영상 진단, 예측 위험도 평가 툴은 수술 후 환자, 임산부, 심방세동 및 암 환자 등 고위험군의 혈전 경향을 감지하는 데 사용되고 있습니다. 이러한 툴을 통해 임상의는 예방적 치료를 조기에 시작하고 입원율을 낮출 수 있습니다. 수술 장면에서는 수술 중 혈전 모니터링과 수술 전후의 항응고 치료 프로토콜이 표준화되어 수술 후 합병증을 최소화할 수 있게 되었습니다.

장기적인 혈전 관리도 확대되고 있으며, 특히 재발이 반복되는 환자나 만성 혈전색전성 폐고혈압(CTEPH) 환자에 대한 대응이 진행되고 있습니다. 외래 항응고 클리닉, 원격 INR 모니터링, 재택 치료 모델 등으로 평생 혈전 관리가 보다 친숙하고 지속가능한 방식으로 변화하고 있습니다. 또한 바이오마커, 유전적 소인, 동반질환에 따른 환자 계층화가 중요해지면서 보다 정교하고 위험도 조정된 치료 계획을 세울 수 있게 되었습니다. 이러한 정밀한 접근 방식은 맞춤형 투여 요법, 틈새 진단, 맞춤형 기기 개발 등 혈전 치료의 새로운 하위 시장을 창출하고 있습니다.

혈전 치료 시장의 성장을 가속화하는 요인은 무엇인가?

혈전 치료 시장의 성장은 치료 혁신, 중재 기술, 임상 워크플로우 통합과 관련된 여러 가지 수렴 요인에 의해 주도되고 있습니다. 첫째, 안전성, 유효성, 사용 편의성으로 인해 DOAC의 채택이 확대되고 있으며, 입원 및 외래 혈전치료가 재편되고 있습니다. 둘째, 뇌경색, PE, 말초혈전에서 카테터를 이용한 기계적 혈전제거술의 보급은 저침습적 치료의 새로운 기준을 확립하고 있습니다.

셋째, 영상 진단(CT 혈관조영술, 초음파 이중층법 등)의 향상과 AI를 통한 위험도 평가 툴의 사용으로 보다 빠른 진단과 보다 정확한 치료 시작이 가능해졌습니다. 넷째, 인구 고령화, 비만율 증가, 심방세동 유병률 증가 등의 인구통계학적 요인으로 인해 위험 환자군이 확대되어 보다 적극적인 예방적 치료적 개입이 필요하게 되었습니다. 다섯째, 기구의 소형화, 유연한 카테터 기술, 영상 유도 시스템의 통합 등 현재 진행 중인 기술 혁신은 혈관내 치료를 더욱 안전하고 효과적으로 만들고 있습니다. 마지막으로 가치 기반 치료와 일괄 상환 모델로의 전환은 병원들이 합병증, 재입원, 전체 치료 비용을 줄이는 혈전 관리 프로토콜을 채택하도록 유도하고 있습니다. 이러한 움직임의 수렴으로 혈전 치료는 혈관 및 순환기 치료에서 가장 혁신적이고 임상적으로 역동적인 분야 중 하나가 되었습니다.

부문

유형(심방 혈전 유형, 우심방 혈전 유형, 좌심방 혈전 유형, 정맥혈전 유형); 치료(내과적 치료, 항혈소판 치료, 항응고제 치료, 혈전용해 약치료, 외과적 치료, 기타 치료)

조사 대상 기업의 예

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • Bayer AG
  • Boehringer Ingelheim
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Cardinal Health, Inc.
  • Cook Medical
  • Daiichi Sankyo Company, Limited
  • Edwards Lifesciences Corporation
  • Genentech(F. Hoffmann-La Roche)
  • Inari Medical, Inc.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Pfizer Inc.
  • Stryker Corporation

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴로 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.28

Global Thrombus Treatment Market to Reach US$55.7 Billion by 2030

The global market for Thrombus Treatment estimated at US$40.8 Billion in the year 2024, is expected to reach US$55.7 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Atrial Thrombus Type, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$28.0 Billion by the end of the analysis period. Growth in the Right Atrial Thrombus Type segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.1 Billion While China is Forecast to Grow at 8.7% CAGR

The Thrombus Treatment market in the U.S. is estimated at US$11.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Thrombus Treatment Market - Key Trends & Drivers Summarized

Is Thrombus Management Evolving From Emergency Response to Targeted Intervention?

Thrombus treatment, once largely reactive and centered around emergency interventions like anticoagulation and mechanical thrombectomy, is now undergoing a significant transformation. As clinical understanding deepens and treatment algorithms evolve, thrombus management is moving toward earlier, more precise, and patient-specific strategies. A thrombus-a blood clot formed within a vessel-can lead to life-threatening conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), myocardial infarction, and ischemic stroke. The global burden of thromboembolic disorders, amplified by aging populations and sedentary lifestyles, continues to push healthcare systems toward scalable, advanced treatment approaches.

Modern thrombus treatment is characterized by three pillars: pharmacological therapy, catheter-based intervention, and preventive care. While anticoagulants remain the foundation for most treatment plans, catheter-directed thrombolysis, aspiration thrombectomy, and novel mechanical devices are becoming common in high-risk or refractory cases. Additionally, growing awareness and detection capabilities are enabling earlier diagnosis of thrombi, sometimes even before clinical symptoms manifest-leading to preemptive therapy in high-risk patient groups. This paradigm shift is redefining thrombus care from crisis management to continuous risk mitigation and personalized therapy.

How Are Drug Innovations and Endovascular Devices Redefining Care Standards?

On the pharmacological front, the development of direct oral anticoagulants (DOACs) such as apixaban, rivaroxaban, and edoxaban has changed the landscape of thrombus treatment by offering predictable pharmacokinetics, reduced monitoring needs, and lower bleeding risk compared to warfarin. These agents are increasingly used in both hospital and outpatient settings for DVT, PE, and stroke prevention in atrial fibrillation. Research is also advancing into next-generation antithrombotics with higher selectivity and reversal agents that enhance safety profiles for surgical or trauma patients.

Meanwhile, the rise of mechanical thrombectomy and catheter-directed thrombolysis (CDT) is transforming treatment protocols for acute thrombotic events. These minimally invasive procedures allow for targeted clot removal or localized drug delivery, minimizing systemic exposure and bleeding complications. Devices such as aspiration catheters, self-expanding stent retrievers, and ultrasonic-assisted thrombolysis systems are being fine-tuned to enhance efficacy across vascular beds-cerebral, pulmonary, coronary, and peripheral. The ability to combine mechanical and pharmacological therapies in hybrid procedures is yielding faster clot resolution and better functional outcomes, particularly in stroke and PE patients who require immediate restoration of perfusion.

Can Early Detection, Risk Profiling, and Preventive Therapies Expand Market Reach?

A critical trend in thrombus treatment is the emphasis on prevention and early risk identification. Wearable technologies, AI-assisted imaging, and predictive risk scoring tools are being used to detect thrombotic tendencies in high-risk populations-such as post-operative patients, pregnant women, and individuals with atrial fibrillation or cancer. These tools enable clinicians to initiate prophylactic therapy earlier and reduce hospitalization rates. In surgical settings, intraoperative thrombus monitoring and perioperative anticoagulation protocols are being standardized to minimize post-procedure complications.

Long-term thrombus management is also expanding, especially for patients with recurrent events or chronic thromboembolic pulmonary hypertension (CTEPH). Outpatient anticoagulation clinics, remote INR monitoring, and home-based care models are making lifelong thrombus management more accessible and sustainable. Moreover, increasing focus on patient stratification-based on biomarkers, genetic predisposition, and comorbidities-is enabling more refined, risk-adjusted therapy plans. This precision approach is creating new submarkets within thrombus care, including personalized dosage regimens, niche diagnostics, and tailored device deployment.

What Factors Are Accelerating Growth in the Thrombus Treatment Market?

The growth in the thrombus treatment market is driven by multiple converging factors related to therapeutic innovation, interventional techniques, and clinical workflow integration. First, the expanding adoption of DOACs-due to their safety, efficacy, and ease of use-is reshaping both inpatient and outpatient thrombus care. Second, the increasing use of catheter-based and mechanical thrombectomy systems in stroke, PE, and peripheral thrombi is establishing new standards in minimally invasive treatment.

Third, improvements in diagnostic imaging (e.g., CT angiography, duplex ultrasound) and the use of AI-assisted risk assessment tools are enabling faster diagnosis and more accurate therapy initiation. Fourth, demographic factors such as aging populations, rising obesity rates, and the increasing prevalence of atrial fibrillation are swelling the at-risk patient pool, prompting more aggressive prophylactic and therapeutic interventions. Fifth, ongoing innovations in device miniaturization, flexible catheter technologies, and integrated imaging-guided systems are making endovascular approaches safer and more effective. Lastly, the shift toward value-based care and bundled reimbursement models is encouraging hospitals to adopt thrombus management protocols that reduce complications, readmissions, and overall treatment costs. These dynamics are converging to make thrombus treatment one of the most innovation-driven and clinically dynamic segments in vascular and cardiovascular care.

SCOPE OF STUDY:

The report analyzes the Thrombus Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type, Venous Thrombus Type); Treatment (Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment, Surgery Treatment, Other Treatments)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • Bayer AG
  • Boehringer Ingelheim
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Cardinal Health, Inc.
  • Cook Medical
  • Daiichi Sankyo Company, Limited
  • Edwards Lifesciences Corporation
  • Genentech (F. Hoffmann-La Roche)
  • Inari Medical, Inc.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Pfizer Inc.
  • Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Thrombus Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular and Stroke-Related Events Fuels Demand for Thrombus Therapies
    • Adoption of Catheter-Directed Thrombolysis Supports Minimally Invasive Treatment Growth
    • Increased Use of Mechanical Thrombectomy Devices Enhances Acute Stroke Intervention Success
    • Advancements in Clot-Dissolving Agents Improve Efficacy in DVT and PE Management
    • Expansion of Interventional Cardiology Capabilities Drives Procedural Volumes for Clot Removal
    • Rising Awareness of Venous Thromboembolism Prevention in Post-Surgical Settings Supports Prophylactic Drug Use
    • Integration of Imaging Technologies With Treatment Planning Enhances Patient Selection Accuracy
    • Development of Next-Gen Devices With Reduced Embolization Risk Supports Adoption in High-Risk Patients
    • Growth in Stroke Centers and Specialized Units Enhances Access to Timely Thrombus Treatment
    • Demand for Rapid-Recovery Solutions Drives Hospital Preference for Mechanical Devices Over Systemic Agents
    • Increased Investment in Stroke and Vascular Health Campaigns Supports Early Presentation and Diagnosis
    • Growing Pipeline of Anti-Thrombotic Agents Expands Therapeutic Options in Refractory Cases
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Thrombus Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Thrombus Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Atrial Thrombus Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Right Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Right Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Right Atrial Thrombus Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Left Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Left Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Left Atrial Thrombus Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Venous Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Venous Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Venous Thrombus Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Medical Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Medical Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Medical Therapy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Antiplatelets Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Antiplatelets Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Antiplatelets Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Anticoagulants Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Anticoagulants Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Anticoagulants Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Thrombolytics Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Thrombolytics Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Thrombolytics Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Surgery Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Surgery Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Surgery Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • JAPAN
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • CHINA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • EUROPE
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Thrombus Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • FRANCE
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: France 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: France 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • GERMANY
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Thrombus Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • INDIA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: India 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: India 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Thrombus Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Thrombus Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • AFRICA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제